These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23510200)

  • 1. Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registry.
    Wasem J; Bramlage P; Gitt AK; Binz C; Krekler M; Deeg E; Tschöpe D;
    Cardiovasc Diabetol; 2013 Mar; 12():47. PubMed ID: 23510200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.
    Bramlage P; Binz C; Gitt AK; Krekler M; Plate T; Deeg E; Tschöpe D
    Cardiovasc Diabetol; 2010 Sep; 9():53. PubMed ID: 20843379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
    Gitt AK; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Tschöpe D;
    Eur J Prev Cardiol; 2012 Aug; 19(4):765-72. PubMed ID: 21628353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.
    Bramlage P; Gitt AK; Schneider S; Deeg E; Tschöpe D;
    BMC Cardiovasc Disord; 2014 Nov; 14():162. PubMed ID: 25410473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry.
    Gitt AK; Bramlage P; Binz C; Krekler M; Deeg E; Tschöpe D
    Herz; 2012 May; 37(3):294-300. PubMed ID: 22476616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2 years.
    Grandy S; Langkilde AM; Sugg JE; Parikh S; Sjöström CD
    Int J Clin Pract; 2014 Apr; 68(4):486-94. PubMed ID: 24499168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population.
    Jalkanen K; Aarnio E; Lavikainen P; Jauhonen HM; Enlund H; Martikainen J
    Health Qual Life Outcomes; 2019 Jul; 17(1):117. PubMed ID: 31286982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry.
    Tschöpe D; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Gitt AK
    Cardiovasc Diabetol; 2011 Jul; 10():66. PubMed ID: 21756359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis.
    Wermeling PR; Gorter KJ; van Stel HF; Rutten GE
    Cardiovasc Diabetol; 2012 Oct; 11():121. PubMed ID: 23039172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand.
    Pratipanawatr T; Satirapoj B; Ongphiphadhanakul B; Suwanwalaikorn S; Nitiyanant W
    J Diabetes Res; 2019; 2019():5903820. PubMed ID: 31772942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.
    Chancellor J; Aballéa S; Lawrence A; Sheldon R; Cure S; Plun-Favreau J; Marchant N
    Pharmacoeconomics; 2008; 26(3):217-34. PubMed ID: 18282016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EQ-5D in coronary patients: what are they suffering from? Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.
    De Smedt D; Kotseva K; De Backer G; Wood D; Van Wilder L; De Bacquer D
    Qual Life Res; 2020 Apr; 29(4):1037-1046. PubMed ID: 31741215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire.
    Golicki D; Dudzińska M; Zwolak A; Tarach JS
    Adv Clin Exp Med; 2015; 24(1):139-46. PubMed ID: 25923098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients: REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life REVIVAL).
    Cascino TM; Kittleson MM; Lala A; Stehlik J; Palardy M; Pamboukian SV; Ewald GA; Mountis MM; Horstmanshof DA; Robinson SW; Shah P; Jorde UP; McLean RC; Richards B; Khalatbari S; Spino C; Taddei-Peters WC; Grady KL; Mann DL; Stevenson LW; Stewart GC; Aaronson KD;
    Circ Heart Fail; 2020 May; 13(5):e006858. PubMed ID: 32418478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing health-related quality of life in patients with Type 1 diabetes.
    Raymakers AJN; Gillespie P; O'Hara MC; Griffin MD; Dinneen SF
    Health Qual Life Outcomes; 2018 Feb; 16(1):27. PubMed ID: 29394942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks.
    Grandy S; Sternhufvud C; Ryden A; Sugg J; Rohwedder K
    Diabetes Obes Metab; 2016 Mar; 18(3):306-9. PubMed ID: 26537439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of health-related quality of life of Bangladeshi patients with type 2 diabetes using the EQ-5D: a cross-sectional study.
    Saleh F; Ara F; Mumu SJ; Hafez MA
    BMC Res Notes; 2015 Sep; 8():497. PubMed ID: 26420245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the sensitivity of EQ-5D in a sample of patients with type 2 diabetes mellitus in two tertiary health care facilities in Nigeria.
    Ekwunife OI; Ezenduka CC; Uzoma BE
    BMC Res Notes; 2016 Jan; 9():24. PubMed ID: 26758272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.
    Gitt AK; Bramlage P; Schneider S; Tschöpe D
    Cardiovasc Diabetol; 2015 Feb; 14():13. PubMed ID: 25645672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.